Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study (MEDLIP)

Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study (MEDLIP Study)

This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.

Study Overview

• Status: Recruiting
• Conditions: Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students
• Intervention / Treatment: Diagnostic test: Measurement of Lp(a) levels

Detailed Description

Lipoprotein(a) [Lp(a)] has emerged as a prevalent monogenetic cardiovascular risk factor globally. Despite its significance, clinical attention for elevated Lp(a) is suboptimal. This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece, as well as gather data on the demographic characteristics and medical history of this population. Statistical analysis will assess Lp(a) levels, prevalence, and associations with demographic and cardiovascular risk factors. The study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students, emphasizing the importance of awareness, early diagnosis, and management of this cardiovascular risk factor.

• Study Type: Observational
• Enrollment (Estimated): 246

Contacts and Locations

• Study Contact: Name: Fotios Barkas, MD, PhD; Phone Number: +306936636376; Email: f.barkas@uoi.gr
• Study Contact Backup: Name: Marios Kourtidis, MD; Phone Number: +306987415932; Email: markourtidis@gmail.com

Study Locations

• Greece
  • Ioannina
    • Ioánnina, Ioannina, Greece, 45000
      • Recruiting
      • University Hospital of Ioannina
      • Contact: Fotios Barkas, MD, PhD; Phone Number: +306936636376; Email: f.barkas@uoi.gr
      • Contact: Marios Kourtidis, MD; Phone Number: +306987415932; Email: markourtidis@gmail.com
      • Principal Investigator: Fotios Barkas, MD, PhD
      • Sub-Investigator: Marios Kourtidis, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece

Description

Inclusion Criteria:

• Medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece.

Exclusion Criteria:

• Inability/unwillingness to give informed consent

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Med students; Medical students in whom Lp(a) levels will be measured	Diagnostic test: Measurement of Lp(a) levels; Collection of a venous blood sample for the measurement of Lp(a) levels using standardized laboratory methods

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Lp(a) elevated	At time of measurement
Lp(a) beneath cut-off	At time of measurement

Collaborators and Investigators

• Sponsor: University of Ioannina
• Investigators: Principal Investigator: Fotios Barkas, MD, PhD, University of Ioannina

Study record dates

Study Major Dates

• Study Start (Estimated): June 1, 2024
• Primary Completion (Estimated): July 1, 2024
• Study Completion (Estimated): October 1, 2024

Study Registration Dates

• First Submitted: June 25, 2024
• First Submitted That Met QC Criteria: June 25, 2024
• First Posted (Actual): July 1, 2024

Study Record Updates

• Last Update Posted (Actual): July 1, 2024
• Last Update Submitted That Met QC Criteria: June 25, 2024
• Last Verified: June 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Metabolic Diseases; Lipid Metabolism Disorders; Dyslipidemias
• Other Study ID Numbers: MEDLIP Study

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No